1. Synthesis and in vitro anticancer activities of biotinylated derivatives of glaucocalyxin A and oridonin
- Author
-
Xiao-Lei Huang, Li Xianlun, Jian Zhang, Susan L. Morris-Natschke, Ya-Dong Cui, Goto Masuo, Jing-Lei Chen, Yung Yi Cheng, Kuo Hsiung Lee, Lei Zhao, Jiangyun Liu, and Daofeng Chen
- Subjects
Pharmacology ,biology ,Organic Chemistry ,Pharmaceutical Science ,General Medicine ,Carbon-13 NMR ,biology.organism_classification ,In vitro ,Analytical Chemistry ,HeLa ,chemistry.chemical_compound ,Complementary and alternative medicine ,Biotin ,chemistry ,Biochemistry ,Biotinylation ,Drug Discovery ,Cancer cell ,Proton NMR ,Molecular Medicine ,Cytotoxic T cell ,skin and connective tissue diseases - Abstract
Fourteen glaucocalyxin A biotinylated derivatives, one glaucocalyxin C biotinylated derivative, and two oridonin biotinylated derivatives were designed and synthesized. Their structures were confirmed from 1H NMR, 13C NMR and HRMS data. The derivatives were evaluated for cytotoxic activities against lung (A549), cervical cancer cell line HeLa derivative (KB), multidrug-resistant KB subline (KB-VIN), triple-negative breast (MDA-MB-231), and estrogen receptor-positive breast (MCF-7) cancer cell lines.[Formula: see text].
- Published
- 2020